Perfil
David O'Neill currently works at Triphase Accelerator Corp., as Director from 2018.
Dr. O'Neill also formerly worked at Fight Against Cancer Innovation Trust, as President from 2017 to 2025.
Dr. O'Neill received his graduate degree from the University of Western Ontario.
Cargos activos de David O'Neill
| Empresas | Cargo | Inicio |
|---|---|---|
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Director/Miembro de la Junta | 01/01/2018 |
Antiguos cargos conocidos de David O'Neill.
| Empresas | Cargo | Fin |
|---|---|---|
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Inversor de Capital Privado | 06/01/2025 |
Formación de David O'Neill.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Finance |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- David O'Neill
















